Multiple hormone resistance in short children born with intrauterine growth retardation?

被引:25
作者
Chatelain, PG
Nicolino, M
Claris, O
Salle, B
Chaussain, JL
机构
[1] Univ Lyon 1, Hop Debrousse, Fac Med, Dept Pediat,INSERM U418, F-69322 Lyon, France
[2] Univ Lyon 1, Dept Pediat, F-69365 Lyon, France
[3] Univ Lyon 1, Hop Edouard Herriot, Dept Pediat, F-69365 Lyon, France
[4] Univ Paris 05, Hop Paris 5, Dept Pediat, Hop St Vincent de Paul, Paris, France
关键词
intrauterine growth retardation; fetal growth; short stature; growth hormone; treatment; hormone resistance; insulin;
D O I
10.1159/000053082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intrauterine growth retardation (IUGR) is encountered in 2.5% (-2 SD) of newborns. Lack of postnatal catch-up growth is found in 8-20%. If GH secretion is increased early postnatally in IUGR, then some persistently short IUGR children may present with GH insufficiency. However, the mechanism of postnatal catch-up growth is heterogenous. The response to GH treatment with regard to plasma IGF-1, GH dose and growth velocity was analyzed in persistently short idiopathic IUGR children and compared to GH-deficient (GHD) and familial short stature (FSS) children of similar age and degree of short stature. IUGR children require both a greater basal and GH-induced plasma IGF-1 in order to achieve a growth velocity of similar magnitude to that of FSS and GHD children. These data suggest a different sensitivity to GH in IUGR compared to FSS or GHD children, sustaining the hypothesis that these idiopathic IUGR children may be partially IGF-1 resistant. The recent report of partial insulin resistance in IUGR subjects raises the possibility of an IGF-1 receptor- or post-receptor-mediated defect.
引用
收藏
页码:20 / 22
页数:3
相关论文
共 26 条
[1]  
Albertsson-Wikland K, 1989, Acta Paediatr Scand Suppl, V349, P35
[2]   FETAL GROWTH AND ADULT DISEASE [J].
BARKER, DJP .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (04) :275-276
[3]  
CAUDERAY M, 1996, FURTHER EVIDENCE DIF
[4]   AUXOLOGY AND RESPONSE TO GROWTH-HORMONE TREATMENT OF PATIENTS WITH INTRAUTERINE GROWTH-RETARDATION OR SILVER-RUSSELL SYNDROME - ANALYSIS OF DATA FROM THE KABI PHARMACIA INTERNATIONAL GROWTH STUDY [J].
CHATELAIN, PG .
ACTA PAEDIATRICA, 1993, 82 :79-81
[5]   ADULT HEIGHT IN CHILDREN WITH PREPUBERTAL SHORT STATURE SECONDARY TO INTRAUTERINE GROWTH-RETARDATION [J].
CHAUSSAIN, JL ;
COLLE, M ;
DUCRET, JP .
ACTA PAEDIATRICA, 1994, 83 :72-73
[6]   A GROWTH-DEFICIENCY PHENOTYPE IN HETEROZYGOUS MICE CARRYING AN INSULIN-LIKE GROWTH FACTOR-II GENE DISRUPTED BY TARGETING [J].
DECHIARA, TM ;
EFSTRATIADIS, A ;
ROBERTSON, EJ .
NATURE, 1990, 345 (6270) :78-80
[7]   FUNCTIONAL HYPERSOMATOTROPISM IN SMALL FOR GESTATIONAL-AGE (SGA) NEWBORN-INFANTS [J].
DEIBER, M ;
CHATELAIN, P ;
NAVILLE, D ;
PUTET, G ;
SALLE, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (01) :232-234
[8]  
FITZHARD.PM, 1972, PEDIATRICS, V49, P671
[9]   GROWTH RESPONSES TO HUMAN GROWTH-HORMONE IN PATIENTS WITH INTRAUTERINE GROWTH RETARDATION [J].
FOLEY, TP ;
THOMPSON, RG ;
SHAW, M ;
BAGHDASSARIAN, A ;
NISSLEY, SP ;
BLIZZARD, RM .
JOURNAL OF PEDIATRICS, 1974, 84 (05) :635-641
[10]  
Gluckman P., 1992, HUMAN GROWTH BASIC C, P253